These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30140160)

  • 1. Right- and left-sided stage III colon cancers present different prognostic outcomes of oxaliplatin-based adjuvant chemotherapy after curative resection.
    Peng J; Li C; Wang F; Zhang H; Xiao W; Li H; Lu Z; Pan Z; Wu X; Zhang R
    Cancer Manag Res; 2018; 10():2095-2103. PubMed ID: 30140160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer.
    Peng J; Zhang R; Zhao Y; Wu X; Chen G; Wan D; Lu Z; Pan Z
    Chin J Cancer; 2017 Dec; 36(1):96. PubMed ID: 29268783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of oncological outcomes of right-sided colon cancer versus left-sided colon cancer after curative resection: Which side is better outcome?
    Lim DR; Kuk JK; Kim T; Shin EJ
    Medicine (Baltimore); 2017 Oct; 96(42):e8241. PubMed ID: 29049212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of tumor location and mismatch repair on clinicopathological features and survival for non-metastatic colon cancer: A retrospective, single center, cohort study].
    Sun Z; Zhou WX; Li KX; Wu B; Lin GL; Qiu HZ; Niu BZ; Sun XY; Lu JY; Xu L; Xiao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Jun; 27(6):591-599. PubMed ID: 38901992
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of chemotherapy, primary tumor location and histological subtype on the survival of stage III colon cancer patients.
    Zhou C; Lu L; Huang Q; Tang Z; Tang R; Xiao Z; Xiao S
    BMC Gastroenterol; 2023 Apr; 23(1):110. PubMed ID: 37020295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor location impact in stage II and III colon cancer: epidemiological and outcome evaluation.
    Mejri N; Dridi M; El Benna H; Labidi S; Daoud N; Boussen H
    J Gastrointest Oncol; 2018 Apr; 9(2):263-268. PubMed ID: 29755764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Female Sex and Right-Sided Tumor Location Are Poor Prognostic Factors for Patients With Stage III Colon Cancer After a Curative Resection.
    Park JH; Park HC; Park SC; Oh JH; Kim DW; Kang SB; Heo SC; Kim MJ; Park JW; Jeong SY; Park KJ
    Ann Coloproctol; 2018 Dec; 34(6):286-291. PubMed ID: 30630302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncological impact of vascular invasion in colon cancer might differ depending on tumor sidedness.
    Shalkamy MSA; Bae JH; Lee CS; Han SR; Kim JH; Kye BH; Lee IK; Lee YS
    J Minim Invasive Surg; 2022 Jun; 25(2):53-62. PubMed ID: 35821690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-immune-inflammation value as a prognostic biomarker for colon cancer and its variation by primary tumor location.
    Wang QY; Zhong WT; Xiao Y; Lin GL; Lu JY; Xu L; Zhang GN; Du JF; Wu B
    World J Gastroenterol; 2024 Sep; 30(33):3823-3836. PubMed ID: 39351432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of right-sided and left-sided colon cancer after curative resection.
    Yang CY; Yen MH; Kiu KT; Chen YT; Chang TC
    Sci Rep; 2022 Jul; 12(1):11323. PubMed ID: 35790871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
    Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status.
    Taieb J; Kourie HR; Emile JF; Le Malicot K; Balogoun R; Tabernero J; Mini E; Folprecht G; Van Laethem JL; Mulot C; Bouché O; Aparicio T; Michel P; Thaler J; Bridgewater J; Van Cutsem E; Perkins G; Lepage C; Salazar R; Laurent-Puig P;
    JAMA Oncol; 2018 Jul; 4(7):e173695. PubMed ID: 29167892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 627 patients with right- and left-sided colon cancer in China: Differences in clinicopathology, recurrence, and survival.
    Qin Q; Yang L; Sun YK; Ying JM; Song Y; Zhang W; Wang JW; Zhou AP
    Chronic Dis Transl Med; 2017 Mar; 3(1):51-59. PubMed ID: 29063056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience.
    Peng J; Li W; Zhang R; Lin J; Tang J; Wen Y; Lu Z; Wu X; Pan Z
    Cancer Commun (Lond); 2019 Oct; 39(1):59. PubMed ID: 31619288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological differences and correlations between right and left colon cancer.
    Kalantzis I; Nonni A; Pavlakis K; Delicha EM; Miltiadou K; Kosmas C; Ziras N; Gkoumas K; Gakiopoulou H
    World J Clin Cases; 2020 Apr; 8(8):1424-1443. PubMed ID: 32368535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive recurrences determine oncologic outcomes after resection of liver metastases from primary right colon cancer: Results of a case-control study.
    Zimmitti G; Panettieri E; Ardito F; Mele C; Maria V; Rosso E; Nuzzo G; Giuliante F
    Eur J Surg Oncol; 2021 Apr; 47(4):834-841. PubMed ID: 33032866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical baseline and prognostic difference of platelet lymphocyte ratio (PLR) in right-sided and let-sided colon cancers.
    Yang L; He W; Kong P; Jiang C; Yang Q; Xie Q; Xia LP
    BMC Cancer; 2017 Dec; 17(1):873. PubMed ID: 29262803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of primary tumor location and mismatch repair status guides adjuvant chemotherapy in stage II colon cancer.
    Yang L; He W; Yang Q; Kong P; Xie Q; Jiang C; Zhang B; Xia LP
    Oncotarget; 2017 Nov; 8(58):99136-99149. PubMed ID: 29228759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Factors and Differences in Survival of Right and Left Colon Carcinoma: A STROBE Compliant Retrospective Cohort Study.
    Beltrán L; González-Trejo S; Carmona-Herrera DD; Carrillo JF; Herrera-Goepfert R; Aiello-Crocifoglio V; Gallardo-Rincón D; Meléndez-Ponce NA; Ochoa-Carrillo FJ; Oñate-Ocaña LF
    Arch Med Res; 2019 Feb; 50(2):63-70. PubMed ID: 31349955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Worse Prognosis of Right-Sided Compared with Left-Sided Colon Cancers: a Systematic Review and Meta-analysis.
    Yahagi M; Okabayashi K; Hasegawa H; Tsuruta M; Kitagawa Y
    J Gastrointest Surg; 2016 Mar; 20(3):648-55. PubMed ID: 26573851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.